As on May 18, 2021, Arcadia Biosciences Inc. (NASDAQ: RKDA) got off with the flyer as it spiked 1.92% to $2.66. During the day, the stock rose to $2.78 and sunk to $2.51 before settling in for the price of $2.61 at the close. Taking a more long-term approach, RKDA posted a 52-week range of $2.26-$6.40.
The Basic Materials Sector giants’ yearly sales growth during the last 5-year period was 8.20%. Meanwhile, its Annual Earning per share during the time was 45.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.70%. This publicly-traded company’s shares outstanding now amounts to $21.34 million, simultaneously with a float of $19.53 million. The organization now has a market capitalization sitting at $54.26 million. At the time of writing, stock’s 50-day Moving Average stood at $2.67, while the 200-day Moving Average is $3.02.
Let’s gauge the efficiency of the firm, which has a total of 58 employees. It has generated 138,517 per worker during the last fiscal year. Meanwhile, its income per employee was -80,259. The stock had 8.00 Receivables turnover and 0.20 Total Asset turnover. For the Profitability, stocks gross margin was +35.29, operating margin was -267.92 and Pretax Margin of -76.55.
Arcadia Biosciences Inc. (RKDA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Agricultural Inputs industry. Arcadia Biosciences Inc.’s current insider ownership accounts for 8.49%, in contrast to 8.20% institutional ownership. According to the most recent insider trade that took place on Aug 03, this organization’s Chief Executive Officer bought 585 shares at the rate of 3.16, making the entire transaction reach 1,849 in total value, affecting insider ownership by 14,285. Preceding that transaction, on Aug 03, Company’s Chief Technology Officer bought 700 for 3.16, making the whole transaction’s value amount to 2,212. This particular insider is now the holder of 13,000 in total.
Arcadia Biosciences Inc. (RKDA) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/31/2020, the company posted $0.88 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.41) by $1.29. This company achieved a net margin of -57.94 while generating a return on equity of -26.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
Arcadia Biosciences Inc.’s EPS increase for this current 12-month fiscal period is 89.70% and is forecasted to reach -0.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.96% through the next 5 years, which can be compared against the 45.10% growth it accomplished over the previous five years trading on the market.
Arcadia Biosciences Inc. (NASDAQ: RKDA) Trading Performance Indicators
Let’s observe the current performance indicators for Arcadia Biosciences Inc. (RKDA). It’s Quick Ratio in the last reported quarter now stands at 4.40. The Stock has managed to achieve an average true range (ATR) of 0.18. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.78.
In the same vein, RKDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.54, a figure that is expected to reach -0.30 in the next quarter, and analysts are predicting that it will be -0.57 at the market close of one year from today.
Technical Analysis of Arcadia Biosciences Inc. (RKDA)
Through scrutinizing the latest numbers posted by the [Arcadia Biosciences Inc., RKDA], it can be observed that its last 5-days Average volume of 0.88 million was lower the volume of 2.42 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 62.27% While, its Average True Range was 0.18.
Raw Stochastic average of Arcadia Biosciences Inc. (RKDA) in the period of the previous 100 days is set at 9.66%, which indicates a major fall in contrast to 53.45% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 60.19% that was lower than 118.58% volatility it exhibited in the past 100-days period.